quinazolines has been researched along with Pneumonia in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (45.83) | 29.6817 |
| 2010's | 12 (50.00) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Han, B; Huang, W; Li, X; Peng, C; Xie, X; Ye, C; Zhang, N; Zhao, Q; Zhu, HP | 1 |
| Ito, T; Kajiguchi, T; Kamoshita, S; Kimura, T; Yagi, M | 1 |
| Arimura-Omori, M; Hamada, N; Harada, E; Mikumo, H; Nakanishi, Y; Ogata-Suetsugu, S; Suzuki, K; Yanagihara, T | 1 |
| Chen, X; Li, H; Zhou, S | 1 |
| Knoll, BM; Phillips, A; Seiter, K; Soave, R | 1 |
| Chen, TC; Lee, KM; Lien, CT; Lin, SY; Lu, PL | 1 |
| Hao, Q; Jiao, S; Li, C; Shi, Z; Song, X; Wang, W; Wang, Y; Zhang, Z; Zhao, Y; Zhou, Z | 1 |
| Higashimoto, I; Inoue, H; Kubota, S; Machida, K; Okuno, T; Shirato, M; Watanabe, M; Yokomizo, T | 1 |
| Gerna, G; Lilleri, D | 1 |
| Arimura-Omori, M; Hamada, N; Harada, E; Ikeda-Harada, C; Mikumo, H; Nakanishi, Y; Ogata-Suetsugu, S; Suzuki, K; Yanagihara, T; Yokoyama, T | 1 |
| Fukuhara, T; Inoue, A; Kanehira, M; Kikuchi, T; Kuroki, Y; Maemondo, M; Nukiwa, T; Saijo, Y; Suzuki, T; Xin, H | 1 |
| Hammersley, JR; Kanjwal, S; Taj, A | 1 |
| Chang, FT; Kung, YC; Liaw, SF; Lin, CC; Lin, MW | 1 |
| Atagi, S; Fukuoka, M; Ichinose, Y; Ishikura, S; Niho, S; Ohe, Y; Okamoto, H; Saijo, N; Shibata, T; Takeda, K; Tamura, T; Yokoyama, A | 1 |
| Cyranoski, D | 1 |
| Ando, Y; Nagashima, F; Narabayashi, M; Ohyanagi, F; Sasaki, Y | 1 |
| Damon, IK; Kim, M; Kim, SK; Morehead, TJ; Reche, PA; Reinherz, EL; Welsh, RM; Yang, H | 1 |
| Hotta, K; Inoue, A; Kiura, K; Nukiwa, T; Tanimoto, M; Ueoka, H | 1 |
| Jin, SM; Kim, SR; Lee, KS; Lee, YC; Min, KH; Park, SJ; Puri, KD | 1 |
| Chowbay, B; Goh, JW; Lee, P; Mancer, K; Tan, PH; Toh, CK | 1 |
| Esmaili, A; Vahid, B | 1 |
| Botwood, N; James, R; Price, P; Vernon, C | 1 |
| Broadley, KJ; Spruntulis, LM | 1 |
1 review(s) available for quinazolines and Pneumonia
| Article | Year |
|---|---|
Strategies to control human cytomegalovirus infection in adult hematopoietic stem cell transplant recipients.
Topics: Acetates; Adult; Animals; Antiviral Agents; Asymptomatic Diseases; Benzimidazoles; Clinical Trials as Topic; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Disease Management; Gastroenteritis; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy; Monitoring, Immunologic; Organophosphonates; Pneumonia; Postoperative Complications; Quinazolines; Ribonucleosides | 2016 |
3 trial(s) available for quinazolines and Pneumonia
| Article | Year |
|---|---|
Induction chemotherapy followed by gefitinib and concurrent thoracic radiotherapy for unresectable locally advanced adenocarcinoma of the lung: a multicenter feasibility study (JCOG 0402).
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Feasibility Studies; Female; Gefitinib; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Patient Compliance; Pneumonia; Quinazolines; Treatment Outcome; Vinblastine; Vinorelbine | 2012 |
Gefitinib should be cautiously administered to poor performance status patients with non-small-cell lung cancer: results from a prospective feasibility study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Contraindications; Cystitis; Feasibility Studies; Female; Gastrointestinal Diseases; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Pneumonia; Quinazolines; Vomiting | 2005 |
Raltitrexed ('Tomudex') and radiotherapy can be combined as postoperative treatment for rectal cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Neutropenia; Pneumonia; Quinazolines; Radiotherapy, Adjuvant; Rectal Neoplasms; Thiophenes; Treatment Outcome | 2000 |
20 other study(ies) available for quinazolines and Pneumonia
| Article | Year |
|---|---|
Evodiamine alleviates lipopolysaccharide-induced pulmonary inflammation and fibrosis by activating apelin pathway.
Topics: Animals; Apelin; Apoptosis; Cytokines; Evodia; Fibrosis; Humans; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Plant Extracts; Pneumonia; Quinazolines; RAW 264.7 Cells | 2021 |
Drug-induced interstitial pneumonitis in essential thrombocythemia treated with anagrelide.
Topics: Aged; Female; Humans; Lung Diseases, Interstitial; Platelet Aggregation Inhibitors; Pneumonia; Quinazolines; Thrombocythemia, Essential; Treatment Outcome | 2017 |
Treatment with a programmed cell death-1-specific antibody has little effect on afatinib- and naphthalene-induced acute pneumonitis in mice.
Topics: Acute Disease; Afatinib; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Dose-Response Relationship, Drug; Female; Humans; Mice, Inbred C57BL; Naphthalenes; Pneumonia; Programmed Cell Death 1 Receptor; Quinazolines; Treatment Outcome | 2017 |
Evodiamine alleviates severe pneumonia induced by methicillin-susceptible Staphylococcus aureus following cytomegalovirus reactivation through suppressing NF-κB and MAPKs.
Topics: Animals; Blotting, Western; Cell Line; Cytomegalovirus; Female; Humans; Interleukin-1beta; Interleukin-6; Methicillin; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; NF-kappa B; Pneumonia; Quinazolines; Signal Transduction; Staphylococcus aureus; Tumor Necrosis Factor-alpha | 2018 |
Breakthrough cytomegalovirus pneumonia in hematopoietic stem cell transplant recipient on letermovir prophylaxis.
Topics: Acetates; Cytomegalovirus; Female; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Pneumonia; Quinazolines; Transplantation Conditioning | 2019 |
A swollen knee in a 77-year-old lung cancer patient receiving antimicrobial therapy for pneumonia.
Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents; Erlotinib Hydrochloride; Fatal Outcome; Humans; Knee; Knee Injuries; Lung Neoplasms; Male; Pneumonia; Quinazolines | 2013 |
The Transitional Endoplasmic Reticulum ATPase p97 Regulates the Alternative Nuclear Factor NF-κB Signaling via Partial Degradation of the NF-κB Subunit p100.
Topics: Adaptor Proteins, Vesicular Transport; Animals; beta Karyopherins; Cell Line, Tumor; Endoplasmic Reticulum; Fibroblasts; Gene Expression Regulation; HEK293 Cells; Humans; Intracellular Signaling Peptides and Proteins; Lipopolysaccharides; Lung; Lymphocytes; Male; Mice; Mice, Knockout; NF-kappa B p52 Subunit; Nuclear Proteins; Pneumonia; Proteasome Endopeptidase Complex; Proteins; Proteolysis; Quinazolines; Signal Transduction; SKP Cullin F-Box Protein Ligases; Transcription, Genetic; Ubiquitination | 2015 |
An inhaled phosphodiesterase 4 inhibitor E6005 suppresses pulmonary inflammation in mice.
Topics: Administration, Inhalation; Animals; Bronchoalveolar Lavage Fluid; Chemokines; Female; Lipid Metabolism; Lipopolysaccharides; Lung; Mice; Mice, Inbred C57BL; Phosphodiesterase 4 Inhibitors; Phthalic Acids; Pneumonia; Quinazolines | 2015 |
Neutrophil elastase inhibitor sivelestat ameliorates gefitinib-naphthalene-induced acute pneumonitis in mice.
Topics: Acute Disease; Animals; Bronchoalveolar Lavage Fluid; Female; Gefitinib; Glycine; Humans; Kaplan-Meier Estimate; Leukocyte Count; Leukocyte Elastase; Lung; Mice, Inbred C57BL; Naphthalenes; Neutrophils; Pneumonia; Quinazolines; Serine Proteinase Inhibitors; Sulfonamides; Weight Loss | 2017 |
Suppression of surfactant protein A by an epidermal growth factor receptor tyrosine kinase inhibitor exacerbates lung inflammation.
Topics: Adenocarcinoma; Animals; Gefitinib; Gene Expression; Humans; In Vitro Techniques; Lipopolysaccharides; Lung Diseases, Interstitial; Mice; Pneumonia; Protein Kinase Inhibitors; Pulmonary Surfactant-Associated Protein A; Quinazolines; Signal Transduction | 2008 |
New-onset acute interstitial lung disease after treatment with erlotinib in a patient with metastatic squamous cell carcinoma of the lung.
Topics: Aged; Biopsy; Brain Neoplasms; Carcinoma, Squamous Cell; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Pneumonia; Quinazolines; Tomography, X-Ray Computed | 2011 |
Effects of erlotinib on pulmonary function and airway remodeling after sensitization and repeated allergen challenge in Brown-Norway rats.
Topics: Airway Remodeling; Allergens; Animals; Bronchial Hyperreactivity; Erlotinib Hydrochloride; Immunohistochemistry; Ovalbumin; Pneumonia; Protein Kinase Inhibitors; Quinazolines; Rats; Rats, Inbred BN; Reverse Transcriptase Polymerase Chain Reaction | 2011 |
Biologists take tentative steps towards bespoke cancer drugs.
Topics: Antineoplastic Agents; Gefitinib; Gene Expression Profiling; Humans; Lung Neoplasms; Pharmacogenetics; Pneumonia; Polymorphism, Single Nucleotide; Protein-Tyrosine Kinases; Quinazolines | 2003 |
Acute gefitinib-induced pneumonitis.
Topics: Acute Disease; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Fatal Outcome; Female; Gefitinib; Humans; Lung Neoplasms; Middle Aged; Pneumonia; Quinazolines; Respiratory Insufficiency | 2004 |
Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction.
Topics: Animals; Chlorocebus aethiops; DNA; ErbB Receptors; Growth Substances; HeLa Cells; Humans; Male; Mice; Morpholines; Pneumonia; Protein Transport; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-cbl; Quinazolines; Signal Transduction; Smallpox; T-Lymphocytes; Ubiquitin-Protein Ligases; Vaccinia; Vaccinia virus; Variola virus; Vero Cells; Viral Proteins | 2005 |
Expect the unexpected.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Gefitinib; Heart Diseases; Humans; Multiple Organ Failure; Neoplasms; Pneumonia; Quinazolines | 2006 |
Phosphoinositide 3-kinase-delta inhibitor reduces vascular permeability in a murine model of asthma.
Topics: Adenine; Animals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Capillary Permeability; Cinnamates; Class I Phosphatidylinositol 3-Kinases; Cytokines; Disease Models, Animal; Enzyme Inhibitors; Female; Hypoxia-Inducible Factor 1, alpha Subunit; Indoles; Leukocyte Count; Lung; Mice; Mice, Inbred BALB C; Ovalbumin; Phosphoinositide-3 Kinase Inhibitors; Pneumonia; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor A | 2006 |
An inflammatory response with worsening of pleural effusion on treatment with erlotinib in non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Middle Aged; Pleural Effusion; Pneumonia; Protein Kinase Inhibitors; Quinazolines; Radiography; Treatment Outcome | 2007 |
Erlotinib-associated acute pneumonitis: report of two cases.
Topics: Acute Disease; Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Fatal Outcome; Female; Glucocorticoids; Humans; Lung Neoplasms; Male; Methylprednisolone; Middle Aged; Pneumonia; Protein Kinase Inhibitors; Quinazolines; Shock, Septic | 2007 |
A3 receptors mediate rapid inflammatory cell influx into the lungs of sensitized guinea-pigs.
Topics: Adenosine Monophosphate; Animals; Bronchial Provocation Tests; Bronchoconstriction; Dose-Response Relationship, Drug; Guinea Pigs; Histamine; Leukocyte Count; Leukocytes; Lung; Male; Ovalbumin; Pneumonia; Purinergic P1 Receptor Antagonists; Quinazolines; Receptor, Adenosine A3; Receptors, Purinergic P1; Triazoles | 2001 |